Skip to content

Interview with Artios’ CEO following Biotech and Money’s Awards 2017

| Media coverage

Artios Pharma scooped two awards at the Biotech and Money Awards 2017. The DNA Damage Response company was named winner in the UK Life Science Young Company of the Year (1-3 years old) category and the UK Private Finance Raise of the Year (≤£25 million) category. Biotech and Money spoke to Artios Pharma’s Chief Executive Officer about the wins, the company’s plans for the year ahead, and why it is such an exciting time to be working in the field of DNA repair.